Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q1 2023 · 10-Q
Revenue$0.00$0.00no prior Q1 2022 on file Net Income-$8.04M-$8.04MN/M vs Q1 2022 EPS Diluted-$0.09-$0.09N/M vs Q1 2022 Operating Income-$8,382,649N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
Free Cash Flowderived-$16,117,571N/M ended Mar 31, 2023 · filed May 11, 2023 · 41 d after period end